drugset / Trial / NCT01568047
Multicentre Study in Four Parallel Groups of Parkinson's Disease (PD) Patients
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to investigate the tolerability and the effect of BIA 9-1067 at steady-state on the levodopa pharmacokinetics in Parkinson's Disease (PD) patients treated with levodopa/dopa-decarboxylase inhibitor.
Timeline
- Start
- 2010-02
- Primary completion
- 2010-06
- Completion
- 2010-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Levodopa | Unknown | 100 mg | — |
| Subject | Opicapone | Small molecule | 5 mg | — |
| Subject | Opicapone | Small molecule | 15 mg | — |
| Subject | Opicapone | Small molecule | 30 mg | — |
| Background | Benzerazide | Unknown | 25 mg | — |
| Background | Carbidopa | Unknown | 25 mg | — |